Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Annual report 2 on exploitation, dissemination and outreach (se abrirá en una nueva ventana)

Annual report 2 on exploitation dissemination and outreach activities

Manuscript on validation of epigenetic drug targets in rhabdomyosarcoma (se abrirá en una nueva ventana)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on novel targets of Ewing sarcoma EMT (se abrirá en una nueva ventana)

A manuscript on novel targets of Ewing sarcoma EMT will at least be drafted, aiming to eventually be published in a peer-reviewed journal.The manuscript itself will have to remain confidential until it is published, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript describing (i) the landscape of the surfaceome in Medullo, (ii) from this data: functional validation of a novel target (se abrirá en una nueva ventana)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on in vitro testing of gdTcells in paediatric cancer (se abrirá en una nueva ventana)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Annual report 3 on exploitation, dissemination and outreach (se abrirá en una nueva ventana)

Annual report 3 on exploitation, dissemination and outreach activities

Annual report 1 on exploitation, dissemination and outreach (se abrirá en una nueva ventana)

Annual report 1 on exploitation dissemination and outreach activities

Manuscript on evidence-based recommendation for efficacious precision medicine/ conventional chemotherapeutic drug combinations in drug development programs for children with leukemia (se abrirá en una nueva ventana)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on validation of one targeted immune intervention based on in silico and in vitro analysis (se abrirá en una nueva ventana)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on role of chromatin remodeling in neuroblastoma (se abrirá en una nueva ventana)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Annual report 4 on exploitation, dissemination and outreach (se abrirá en una nueva ventana)

Annual report 4 on exploitation, dissemination and outreach activities

Manuscript on epigenetic processes driving SMARCB1 /SMARCB4 deficient paediatric tumours (se abrirá en una nueva ventana)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on the diagnostic/prognostic value of exosome-associated miRNAs in sarcomas (se abrirá en una nueva ventana)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Publicaciones

Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma (se abrirá en una nueva ventana)

Autores: Salih Demir, Negin Razizadeh, Emilie Indersie, Sophie Branchereau, Stefano Cairo, Roland Kappler
Publicado en: Hepatology Communications, Edición 8, 2024, ISSN 2471-254X
Editor: Hepatology Communications
DOI: 10.1097/hc9.0000000000000378

Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions (se abrirá en una nueva ventana)

Autores: Joaquín J. Maqueda, Alessandra De Feo, Katia Scotlandi
Publicado en: Biomolecules, Edición 14, 2025, Página(s) 1306, ISSN 2218-273X
Editor: Cancers
DOI: 10.3390/biom14101306

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles (se abrirá en una nueva ventana)

Autores: Alessandra De Feo, Marcello Manfredi, Caterina Mancarella, Joaquín J. Maqueda, Veronica De Giorgis, Ymera Pignochino, Marika Sciandra, Camilla Cristalli, Massimo Donadelli, Katia Scotlandi
Publicado en: International Journal of Molecular Sciences, Edición 25, 2024, Página(s) 1588, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms25031588

Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma (se abrirá en una nueva ventana)

Autores: Muhammad Rishfi, Simon Krols, Fien Martens, Sarah-Lee Bekaert, Ellen Sanders, Aline Eggermont, Fanny De Vloed, Joshua Robert Goulding, Martijn Risseeuw, Jan Molenaar, Bram De Wilde, Serge Van Calenbergh, Kaat Durinck
Publicado en: European Journal of Medicinal Chemistry, Edición 247, 2023, Página(s) 115033, ISSN 0223-5234
Editor: Elsevier BV
DOI: 10.1016/j.ejmech.2022.115033

Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy (se abrirá en una nueva ventana)

Autores: Judith Wienke, Lindy L. Visser, Waleed M. Kholosy, Kaylee M. Keller, Marta Barisa, Evon Poon, Sophie Munnings-Tomes, Courtney Himsworth, Elizabeth Calton, Ana Rodriguez, Ronald Bernardi, Femke van den Ham, Sander R. van Hooff, Yvette A.H. Matser, Michelle L. Tas, Karin P.S. Langenberg, Philip Lijnzaad, Anne L. Borst, Elisa Zappa, Francisca J. Bergsma, Josephine G.M. Strijker, Bronte M. Verhoeven,
Publicado en: Cancer Cell, 2024, ISSN 1535-6108
Editor: Cell Press
DOI: 10.1016/j.ccell.2023.12.008

Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challenges (se abrirá en una nueva ventana)

Autores: Elisa Zappa, Alice Vitali, Kathleen Anders, Jan J. Molenaar, Judith Wienke, Annette Künkele
Publicado en: European Journal of Cancer, Edición 194, 2024, Página(s) 113347, ISSN 0959-8049
Editor: Pergamon Press Ltd.
DOI: 10.1016/j.ejca.2023.113347

Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving <i>ALK</i>-Targeted Therapy (se abrirá en una nueva ventana)

Autores: Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah-Planchon, Alexandra Saint-Charles, Angela Bellini, Jaydutt Bhalshankar, Gaelle Pierron, Valérie Combaret, Valéry Attignon, Nicolas André, Nadège Corradini, Benoit Dumont, Ludovic Mansuy, Camille Khanfar, Sebastien Klein, Claire Briandet, Dominique Plantaz, Frederic Millot, Sandrine Thouvenin, Isabelle Aerts, Lee Aymar Ndounga-
Publicado en: Clinical Cancer Research, Edición 30, 2024, Página(s) 3316-3328, ISSN 1078-0432
Editor: American Association for Cancer Research
DOI: 10.1158/1078-0432.ccr-24-0753

Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression (se abrirá en una nueva ventana)

Autores: Ryo Shiraishi, Gabriele Cancila, Kohei Kumegawa, Jacob Torrejon, Irene Basili, Flavia Bernardi, Patricia Benites Goncalves da Silva, Wanchen Wang, Owen Chapman, Liying Yang, Maki Jami, Kayo Nishitani, Yukimi Arai, Zhize Xiao, Hua Yu, Valentina Lo Re, Véronique Marsaud, Julie Talbot, Bérangère Lombard, Damarys Loew, Maho Jingu, Konstantin Okonechnikov, Masaki Sone, Norio Motohashi, Yoshitsugu Ao
Publicado en: Developmental Cell, Edición 59, 2024, Página(s) 2302-2319.e12, ISSN 1534-5807
Editor: Cell Press
DOI: 10.1016/j.devcel.2024.05.013

Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro (se abrirá en una nueva ventana)

Autores: Ronja Pscheid, Esther Drent, Judith Wienke, Josephine G. M. Strijker, Mark Throsby, Jan J. Molenaar
Publicado en: The Journal of Immunology, Edición 211, 2025, Página(s) 229-240, ISSN 0022-1767
Editor: American Association of Immunologists
DOI: 10.4049/jimmunol.2200573

Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function (se abrirá en una nueva ventana)

Autores: Marta Barisa, Elisa Zappa, Henrike Muller, Rivani Shah, Juliane Buhl, Benjamin Draper, Courtney Himsworth, Chantelle Bowers, Sophie Munnings-Tomes, Marilena Nicolaidou, Sonia Morlando, Katie Birley, Clara Leboreiro-Babe, Alice Vitali, Laura Privitera, Kyle O’Sullivan, Ailsa Greppi, Magdalena Buschhaus, Mario Barrera Román, Sam de Blank, Femke van den Ham, Brenna R. van ‘t Veld, Gabrielle Ferr
Publicado en: 2024
Editor: Cold Spring Harbor Laboratory
DOI: 10.1101/2024.02.19.580939

YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1 mediated reprogramming of bone mesenchymal stem cells (se abrirá en una nueva ventana)

Autores: Rahil Noorizadeh, Barbara Sax, Tahereh Javaheri, Branka Radic Sarikas, Valerie Fock, Maximilian Kauer, Aleksandr Bykov, Veveeyan Suresh, Michaela Schlederer, Lukas Kenner, Gerhard Weber, Wolfgang Mikulits, Florian Halbritter, Richard Moriggl, Heinrich Kovar
Publicado en: 2024
Editor: Cold Spring Harbor Laboratory
DOI: 10.1101/2024.07.15.603565

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles

Mi folleto 0 0